1,4-Bis(3-aminopropyl)piperazine - CAS 7209-38-3
Catalog: |
BB034539 |
Product Name: |
1,4-Bis(3-aminopropyl)piperazine |
CAS: |
7209-38-3 |
Synonyms: |
3-[4-(3-aminopropyl)piperazin-1-yl]propan-1-amine |
IUPAC Name: | 3-[4-(3-aminopropyl)piperazin-1-yl]propan-1-amine |
Description: | 1,4-Bis(3-aminopropyl)piperazine (CAS# 7209-38-3) is a useful research chemical. |
Molecular Weight: | 200.32 |
Molecular Formula: | C10H24N4 |
Canonical SMILES: | C1CN(CCN1CCCN)CCCN |
InChI: | InChI=1S/C10H24N4/c11-3-1-5-13-7-9-14(10-8-13)6-2-4-12/h1-12H2 |
InChI Key: | XUSNPFGLKGCWGN-UHFFFAOYSA-N |
Boiling Point: | 150-152 °C (2 mmHg) |
Melting Point: | 15 °C |
Purity: | 99 % |
Density: | 0.973 g/cm3 |
Appearance: | Colorless to yellow liquid |
MDL: | MFCD00006161 |
LogP: | 0.57800 |
GHS Hazard Statement: | H302 (14.14%): Harmful if swallowed [Warning Acute toxicity, oral] |
Precautionary Statement: | P260, P261, P264, P270, P272, P273, P280, P301+P312, P301+P330+P331, P302+P352, P303+P361+P353, P304+P340, P305+P351+P338, P310, P312, P321, P322, P330, P333+P313, P363, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
CN-113332860-A | Preparation and application of high-permselectivity magnesium-lithium separation nanofiltration membrane | 20210611 |
CN-113209022-A | Cationic liposome, preparation method and application thereof in delivery and anti-tumor of bacterial effector protein | 20210430 |
CN-112941655-A | Nano-fiber bilirubin adsorbent and preparation method thereof | 20210330 |
JP-2021080483-A | Complex | 20210304 |
CN-112979585-A | Quaternizable polysulfonic acid ion chain extender and preparation method and application thereof | 20210122 |
PMID | Publication Date | Title | Journal |
22106456 | 20111030 | Retraction notice to 'Layer silicates modified with 1,4-bis(3-aminopropyl)piperazine for the removal of Th(IV), U(VI) and Eu(III) from aqueous media' [J. Hazard. Mater. 171 (2009) 514-523] | Journal of hazardous materials |
21458112 | 20110601 | New ferrocenic pyrrolo[1,2-a]quinoxaline derivatives: synthesis, and in vitro antimalarial activity--Part II | European journal of medicinal chemistry |
20974504 | 20101201 | Synthesis and in vitro biological evaluation of new polyamine conjugates as potential anticancer drugs | European journal of medicinal chemistry |
21361045 | 20101101 | [Effects of combination of Salvia miltiorrhiza and Panax notoginseng on the pharmacokinetics of their major bioactive components in Beagle dog] | Yao xue xue bao = Acta pharmaceutica Sinica |
20538470 | 20100715 | Synthesis and cytotoxic activity of a new potential DNA bisintercalator: 1,4-Bis{3-[N-(4-chlorobenzo[g]phthalazin-1-yl)aminopropyl]}piperazine | Bioorganic & medicinal chemistry |
Complexity: | 116 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 200.20009678 |
Formal Charge: | 0 |
Heavy Atom Count: | 14 |
Hydrogen Bond Acceptor Count: | 4 |
Hydrogen Bond Donor Count: | 2 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 200.20009678 |
Rotatable Bond Count: | 6 |
Topological Polar Surface Area: | 58.5 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | -1.4 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Piperazines
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS